Open-label, phase I dose-escalation study of sodium selenate, a novel activator of PP2A, in patients with castration-resistant prostate cancer.

British Journal of Cancer
Niall M CorcoranA J Costello

Abstract

Angiogenesis is fundamental to the progression of many solid tumours including prostate cancer. Sodium selenate is a small, water-soluble, orally bioavailable activator of PP2A phosphatase with anti-angiogenic properties. This was a dose-escalation phase I study in men with asymptomatic, chemotherapy-naïve, castration-resistant prostate cancer. The primary objective was to determine the maximum tolerated dose (MTD). Secondary objectives included establishing the safety, tolerability and pharmacokinetic profile. A total of 19 patients were enrolled. The MTD was 60 mg per day. Dose-limiting toxicity (fatigue and diarrhoea) was observed at 90 mg per day. The most frequently reported treatment-related adverse events across all treatment cohorts were nausea, diarrhoea, fatigue, muscle spasms, alopecia and nail disorders. No grade 4 toxicities were observed and there were no deaths on study. Linear pharmacokinetics was observed. One patient had a PSA response >50%. Median time to PSA progression (for non-responders) was 14.2 weeks. Mean PSA doubling time increased during the main treatment phase from 2.18 months before trial to 3.85 months. Sodium selenate is well tolerated at a dose of 60 mg per day with modest single-agent efficacy...Continue Reading

References

Jan 3, 1991·The New England Journal of Medicine·N WeidnerJ Folkman
Aug 12, 1971·The New England Journal of Medicine·J Folkman
Jun 20, 2002·Journal of the National Cancer Institute·Lynn HlatkyJudah Folkman
Jul 13, 2002·International Journal of Cancer. Journal International Du Cancer·M Rita I YoungJeremy Meisinger
Jan 10, 2004·The Journal of Urology·Niall M CorcoranAnthony J Costello
Apr 20, 2004·Cancer Causes & Control : CCC·P D BaadeJ F Aitken
Oct 13, 2005·Virchows Archiv : an International Journal of Pathology·Karsten GravdalLars A Akslen
Jun 8, 2006·Journal of the National Cancer Institute·Sun-Jin KimIsaiah J Fidler
Oct 31, 2006·The Journal of Urology·Timothy J DaskivichWilliam K Oh
Jan 4, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Xin YaoBin Tean Teh
Dec 7, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K N ChiL Seymour
Mar 4, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Howard I ScherUNKNOWN Prostate Cancer Clinical Trials Working Group
Jul 4, 2008·Nature Reviews. Cancer·Lee M Ellis, Daniel J Hicklin
Jul 25, 2008·Nature Reviews. Cancer·Gabriele Bergers, Douglas Hanahan
Aug 7, 2008·Nature Clinical Practice. Urology·Harry D GeorgiouChristopher M Hovens
Dec 5, 2008·Cancer Letters·Young-Sun KimJoo-Won Jeong
Mar 24, 2009·Methods in Molecular Biology·Zubair Ahmed, Roy Bicknell
May 1, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M Dror MichaelsonM R Smith
May 29, 2009·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Jul 21, 2009·Current Molecular Pharmacology·Jeanny B Aragon-Ching, William L Dahut
Sep 9, 2009·Nature Reviews. Clinical Oncology·S Percy IvyBennett M Kaufman
Oct 28, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lorelei A MucciSteven K Clinton
Mar 24, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Yang-Min NingWilliam L Dahut
Jun 12, 2010·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Niall M CorcoranChristopher M Hovens

❮ Previous
Next ❯

Citations

Mar 19, 2013·Oncogene·J StebbingG Giamas
Jun 8, 2011·Future Medicinal Chemistry·Michael VoronkovJeffry B Stock
Mar 17, 2015·Brain : a Journal of Neurology·Sandy R ShultzTerence J O'Brien
Aug 18, 2016·Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine·Jan AasethUrban Alehagen
Jul 23, 2016·Journal of Alzheimer's Disease : JAD·Charles B MalpasTerence J O'Brien
Sep 7, 2018·Biological Trace Element Research·Stephen O EvansMichael B Jameson
Jun 12, 2020·Epilepsia Open·Pablo M Casillas-EspinosaTerence J O'Brien
Oct 18, 2018·International Journal of Molecular Sciences·Richard J LobbMichael B Jameson
Jun 25, 2018·Neurobiology of Disease·Patricia G SalettiAristea S Galanopoulou
Apr 2, 2011·Current Opinion in Urology

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.